Adage Capital Partners’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-200,000
| Closed | -$5.08M | – | 838 |
|
|
2020
Q2 | $5.08M | Sell |
200,000
-50,000
| -20% | -$1.27M | 0.01% | 619 |
|
|
2020
Q1 | $4.59M | Sell |
250,000
-150,000
| -38% | -$2.76M | 0.01% | 581 |
|
|
2019
Q4 | $8.81M | Sell |
400,000
-2,150,000
| -84% | -$47.4M | 0.02% | 556 |
|
|
2019
Q3 | $36.6M | Sell |
2,550,000
-250,000
| -9% | -$3.59M | 0.09% | 254 |
|
|
2019
Q2 | $44.1M | Sell |
2,800,000
-250,000
| -8% | -$3.94M | 0.11% | 224 |
|
|
2019
Q1 | $44.7M | Hold |
3,050,000
| – | – | 0.11% | 216 |
|
|
2018
Q4 | $32.6M | Buy |
3,050,000
+600,000
| +24% | +$6.41M | 0.09% | 245 |
|
|
2018
Q3 | $37.4M | Hold |
2,450,000
| – | – | 0.08% | 272 |
|
|
2018
Q2 | $30M | Buy |
2,450,000
+725,000
| +42% | +$8.88M | 0.07% | 313 |
|
|
2018
Q1 | $16.5M | Sell |
1,725,000
-250,000
| -13% | -$2.39M | 0.04% | 445 |
|
|
2017
Q4 | $17.8M | Buy |
+1,975,000
| New | +$17.8M | 0.04% | 433 |
|